“…As mentioned by the authors, in general, MELAS and Mitochondrial Disorders (MIDs) are considered as multisystem diseases ( Finsterer, 2017 ). The patient obviously manifested with SLEs, seizures, migraine, easy fatigability, lactic acidosis, anemia, and hypoacusis ( Almasi et al, 2017 ). However, in some MELAS patients, additional phenotypic features have been reported, such as short stature, confusion, cognitive impairment, dementia, basal ganglia calcification, ptosis, ophthalmoparesis, visual disturbance, gastrointestinal problems (vomiting and volvulus), renal insufficiency, or neuropathy ( Finsterer, & Frank, 2015 ).…”